NasdaqGS:IDXXMedical Equipment
Idexx Laboratories (IDXX) Margin Strength Reinforces Bullish Earnings Narrative Before Q1 2026
IDEXX Laboratories (IDXX) is coming off a year where trailing twelve month revenue reached about US$4.3 billion and basic EPS was US$13.17, with earnings up 19.3% over the past year. Over recent quarters, revenue has moved from US$954.3 million in Q3 2024 to US$1.1 billion in Q4 2025, while quarterly basic EPS has ranged between roughly US$2.64 and US$3.66, giving you a clear view of how the top and bottom line have been tracking into the latest Q1 2026 update. With net profit margins at...